Status:
COMPLETED
Virtual Mindfulness and Weight Management to Mitigate Risk of Relapse and Improve Wellbeing in Cancer Survivors
Lead Sponsor:
Mayo Clinic
Conditions:
Hematopoietic and Lymphoid System Neoplasm
Malignant Solid Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial tests how well a virtual mindfulness and weight management program to mitigate risk of relapse and improve well being for obese cancer survivors in community practice and rural are...
Detailed Description
PRIMARY OBJECTIVES: I. To assess if a 12-week virtual weight management program with a mindfulness component will improve well-being of obese cancer patients with a specific focus on self-reported me...
Eligibility Criteria
Inclusion
- 18 or over
- Identified stage I, II, or III cancer in remission
- Body mass index (BMI) of 30 or greater
- English as a primary language
- Has access to a device with a camera (computer, tablet, or video capable phone) that has wifi and reliable internet access
Exclusion
- Unable to provide consent
- Eastern Cooperative Oncology Group (ECOG) performance status scale score of 3 or above
Key Trial Info
Start Date :
September 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 2 2024
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT06030427
Start Date
September 8 2023
End Date
January 2 2024
Last Update
October 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Health System-Franciscan Healthcare
La Crosse, Wisconsin, United States, 54601